Why is hypertension often known as the silent killer

Ivan-balvan/iStock/Getty Images Plus

Chronically high blood pressure — or hypertension — can cause damage to your blood vessels and internal organs including your heart. Currently affecting nearly half of adults in the United States, hypertension has been called a silent threat because the condition itself has no symptoms. However, the effect on your body can be life-threatening over time. Engaging in healthy lifestyle behaviors at all stages of life can help to decrease your risk.

What You Can Do about High Blood Pressure

The first thing you can do is visit your doctor for routine checkups. Even though high blood pressure rarely shows symptoms, the abnormal force of blood through the arteries, over time, can cause damage to your organs, including your heart, blood vessels and kidneys. Thus, chronic hypertension increases the risk for cardiovascular disease and other serious health issues.

Know your blood pressure and have it monitored. Regular physicals will determine if your blood pressure is within the healthy limits. A blood pressure of less than 120 over 80 is considered healthy. The top number, known as systolic pressure, often gets more attention when discussing the severity of high blood pressure. However, it's important to keep both numbers in the healthy range. If necessary, your doctor will discuss treatment options and supportive health care. Meanwhile, a registered dietitian nutritionist can provide you with guidance on a healthy lifestyle to help lower your blood pressure.

Age and other Risk Factors

High blood pressure tends to increase with age. Additionally, non-Hispanic Black Americans also are at higher risk of developing pre-hypertension and hypertension than non-Hispanic whites, Hispanics, Asians, Pacific Islanders, American Indians and Alaska Natives. Social determinants of health and access may play a role.

Healthy Lifestyle Choices to Reduce Risk of Hypertension

Focusing on lifestyle changes can help reduce your risk of hypertension. Getting regular physical activity, limiting alcohol intake, avoiding tobacco and focusing on a healthful eating style are all ways to help reduce risk.

Individuals at risk of high blood pressure may be advised to follow the Dietary Approaches to Stop Hypertension diet to lower their blood pressure. The DASH diet is rich in fruits and vegetables and low in saturated fat and sodium. Studies show that the DASH diet can help lower your blood pressure.

Since most Americans are getting too much sodium from the foods they eat, it's important to learn ways to reduce it. Simply lowering sodium intake may have a significant impact on blood pressure and thus improve overall health.

Keeping up with regular health appointments is also important, especially if you have a chronic condition like diabetes. Remember that high blood pressure rarely shows symptoms, so following a healthy lifestyle can help to lower your risk.

REVIEW PAPER

Hypertension – The Silent Killer

More details Hide details

1

Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University, Lublin, Poland

2

Department of Cardiology, Medical University, Lublin, Poland

CORRESPONDING AUTHOR

Katarzyna Sawicka

Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University, Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.

J Pre Clin Clin Res. 2011;5[2]:43–46

KEYWORDS

ABSTRACT

Hypertension is often called ‘the silent killer’ because it shows no early symptoms and, simultaneously, is the single most significant risk factor for atherosclerosis and all clinical manifestations of atherosclerosis. It is an independent predisposing factor for heart failure, coronary artery disease, stroke, renal disease, and peripheral arterial disease. It is the most important risk factor for cardiovascular morbidity and mortality in industrialized countries.

REFERENCES [33]

1.

Mancia G, Grassi G, Kjeldsen SE. Nadciśnienie tętnicze – podręcznik European Society of Hypertension, VIA MEDICA, Gdańsk 2009.

2.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365[9455]:217-223.

3.

Mancia G, De Backer G, Dominiczak A, Cifk ova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HAJ, Zanchetti A. 2007 Guidelines for the management of arterial of hypertension. Th e Task Force for the Management of Arterial Hypertension of the European Society of Hypertension [ESH] and of the European Society of Cardiology [ESC]. Eur Heart J 2007;28:1462-1536.

4.

Carretero OA, Oparil S. Essential hypertension. Part I: defi nition and etiology. Circulation 2000;101[3]:329-335.

5.

Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann NY Acad Sci 2006;1083:77-110.

6.

Lackland DT, Egan BM. Dietary salt restriction and blood pressure in clinical trials. Curr Hypertens Rep 2007;9[4]:314-319.

7.

Pitts SR, Adams RP. Emergency department hypertension and regression to the mean. Ann Emerg Med 1998;31[2]:214-218.

8.

De Leeuw PW, Kroon AA. Hypertension and the Development of Heart Failure. J Cardiovasc Pharmacol 1998;32[Suppl 1]:9-15.

9.

Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am J Cardiol 1971;27:335-346.

10.

Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, Cruickshank JM, Devereux RB, Giles TD, Korsgaard N, Leier CV. Remodeling and reparation of the cardiovascular system. An international perspective. J Am Coll Cardiol 1992;20:3-16.

11.

Houghton JL, Frank MJ, Carr AA, Von Dohlen JW, Prisant LM. Relations among impaired coronary fl ow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990;15:43- 51.

12.

Dunn FG, Pringle SD. Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy. J Hypertens 1993;11:1003-1010.

13.

Fouad-Tarazi FM. Left ventricular diastolic dysfunction in hypertension. Curr Opin Cardiol 1994;9:551-560.

14.

Verma A, Solomon SD. Diastolic dysfunction as a link between hypertension and heart failure. Med Clin North Am 2009; 93[3]:647-664.

15.

Lenihan DJ, Gerson MC, Dorn GW II, Hoit BD, Walsh RA. Eff ects of changes in atrioventricular gradient and contractility on left ventricular fi lling in human diastolic cardiac dysfunction. Am Heart J 1996;132:1179-1188.

16.

Fukuta H, Little WC. Diagnosis of diastolic heart failure. Curr Cardiol Rep 2007;9[3]:224-228.

17.

Schwartzkopff B, Motz W, Vogt M, Strauer BE. Heart failure on the basis of hypertension. Circulation 1993;87[Suppl IV]:66-72.

18.

Cuspidi C, Sala C, Zanchetti A. Management of hypertension in patients with left ventricular hypertrophy. Curr Hypertens Rep 2007;9[6]:498- 505.

19.

Ross R: Th e pathogenesis of atherosclerosis – an update. New Engl J Med 1986;14:488-500.

20.

Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982; 89[10]:1132-1145.

21.

Walsh JB. Hypertensive retinopathy. Description, classifi cation, and prognosis. Ophthalmology 1982;89[10]:1127-1131.

22.

Wong TY, Mitchell P. Hypertensive retinopathy. New Engl J Med 2004;351[22]:2310–2317.

23.

Palm F, Urbanek C, Grau A. Infection, its treatment and the risk of stroke. Curr Vasc Pharmacol 2009;7[2]:146-152.

24.

Lawes C, Bennett D, Feigin V, Rodgers A. Blood pressure and stroke. An overview of published reviews. Stroke 2004; 35:1024-1033.

25.

Sare GM, Geeganage C, Bath PM. High blood pressure in acute ischemic stroke--broadening therapeutic horizons. Cerebrovasc Dis 2009;27[Suppl 1]:156-161.

26.

Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag 2008;4[2]:395-402.

27.

Birns J, Kalra L. Cognitive function and hypertension. J Hum Hyperten 2009;23[2]:86-96.

28.

Isles CG. Management of hypertensive crises. Scott Med J 1995;40[1]: 23-25.

29.

O’Hara McCoy H. Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care. J Am Acad Nurse Pract 2008;20[2]:100-106.

30.

Khosla N, Kalaitzidis R, Bakris GL. Th e kidney, hypertension, and remaining challenges. Med Clin N Am 2009;93[3]:697-715.

31.

Krzesiński JM, Cohen EP. Hypertension and the kidney. Acta Clin Belg 2007;62[1]:5-14.

32.

Palmer BF. Hypertension management in patients with chronic kidney disease. Curr Hypertens Rep 2008;10[5]:367-373.

33.

Ono H, Ono Y. Nephrosclerosis and hypertension. Med Clin N Am 1997;81[6]:1273-1288.

Why is hypertension often called the silent killer quizlet?

High blood pressure is often called “the silent killer” because it typically has no symptoms until after it has done significant damage to the heart and arteries.

Is hypertension also known as the silent killer?

Hypertension is called a "silent killer". Most people with hypertension are unaware of the problem because it may have no warning signs or symptoms. For this reason, it is essential that blood pressure is measured regularly.

Chủ Đề